title: In U.S., biosimilars still await FDA decision.
authors.forename: Joel B
authors.initials: JB
authors.lastname: Finkelstein
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry; D016568:Drugs, Generic / Q000493:pharmacokinetics; D006801:Humans; D007880:Legislation, Drug; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic